Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Wren Capital

Investor type Angel Group
Founders Rajat Malhotra

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 24
Average round size
info
The average size of a deal this fund participated in
$4M
Portfolio companies 20
Rounds per year 2.00
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.17
Exits 3
Key employees 1
Stages of investment
Early Stage Venture
Late Stage Venture
Seed

Areas of investment

  • Biotechnology
  • Health Care
  • Hardware
  • Genetics
  • Medical Device
Summary

Wren Capital is the famous VC, which was founded in 2011. The main department of described VC is located in the London. The venture was found in Europe in United Kingdom.

The fund is generally included in less than 2 deals every year. The higher amount of exits for fund were in 2019. The common things for fund are deals in the range of 1 - 5 millions dollars. The high activity for fund was in 2013. This Wren Capital works on 16 percentage points less the average amount of lead investments comparing to the other organizations.

Among the most successful fund investment fields, there are Pharmaceutical, Medical Device. Among the most popular portfolio startups of the fund, we may highlight LumeJet, Momentum Bioscience, Monica Healthcare. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom. The fund has exact preference in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Wren Capital, startups are often financed by UK Innovation & Science Seed Fund, Midven, Catapult Ventures. The meaningful sponsors for the fund in investment in the same round are UK Innovation & Science Seed Fund, Parkwalk Advisors, Newable Private Investing. In the next rounds fund is usually obtained by Parkwalk Advisors, Midven, IQ Capital.

This organization was formed by Rajat Malhotra. Besides them, we counted 1 critical employee of this fund in our database.

Read more

Funds with similar focus

Funds from United Kingdom
Funds with similar focus located in United Kingdom:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
BR Angels Brazil, São Paulo, Sao Paulo
Charter Communications Connecticut, Stamford, United States
Cintrifuse Cincinnati, Ohio, United States
Crohn's & Colitis Foundation of America Hatfield, Hertfordshireshire, United Kingdom
D. One Vision Management (DOV) New York, New York, United States
FUJIFILM Chiyoda, Japan
GW Ventures California, San Mateo, United States
Ionis Pharmaceuticals California, Carlsbad, United States
Kyowa Hakko Kogy -
Marubeni America Corporation New York, New York, United States
Norwegian Research Council Norway, Oslo
PSINet Ventures Herndon, United States, Virginia
Qianhai Hengji Jiahui China, Guangdong, Shenzhen
SODICAL Castilla y Leon, Spain, Valladolid
Sprint Vc New York, New York, United States
Swiss Founders Fund Sankt Gallen, Sankt Gallen, Switzerland
TechMinsk Belarus, Minsk
Techstars & The Heritage Group Hardtech Accelerator Indiana, Indianapolis, United States
TheClubDeal Belgium, Brussels-Capital, Uccle
Xing Fu Cheng -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

MitoRx Therapeutics

Biotechnology
Therapeutics
25 Apr 2022 Harwell, Oxfordshire, United Kingdom

Adapttech

Biotechnology
Medical Device
$3M06 Apr 2022 Birmingham, England, United Kingdom

Centauri Therapeutics

Biotechnology
Genetics
Health Care
Medical
Therapeutics
$32M16 Feb 2022 United Kingdom, England, United Kingdom

Adapttech

Biotechnology
Medical Device
$2M23 Mar 2021 Birmingham, England, United Kingdom

Antiverse

Artificial Intelligence
Biotechnology
Health Care
Life Science
Software
$1M15 Mar 2021 Cardiff, United Kingdom

Spotta

Hospitality
Housekeeping Service
$1M28 Jul 2020 Cambridge, England, United Kingdom

Sarissa Biomedical

Biotechnology
Health Care
Medical
$1M28 May 2020 Coventry, England, United Kingdom

Procarta Biosystems

Biotechnology
Health Care
Pharmaceutical
Therapeutics
$1M05 Mar 2019 United Kingdom, England

Oxford Space Systems

Aerospace
Hardware
$9M14 Jun 2018 United Kingdom, England
News
Adapttech Raises £2M in Funding

– Adapttech, a Birmingham, UK-based biomedical startup, raised £2m in funding.
– The round was supported by existing investors including the MEIF Proof of Concept & Early Stage Fund, which is managed by Mercia and part of the Midlands Engine Investment Fund, Bionova Capital (formerly Hovione Capital), as well as new investors including ACF Investors, Wealth Club and Wren Capital.
– The company intends to use the funds to develop new technologies and grow sales of its system for improving the fitting of prosthetic devices.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Wren Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: